Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Improving diversity in medical research

Nature Reviews Disease Primers volume 7, Article number: 74 (2021) Cite this article

Subjects

Clinical research is essential for the advancement of medicine; however, trials often enrol homogeneous populations that do not accurately represent the patient populations served. Representative and diverse research participation is necessary to establish fair standards of care, minimize outcome disparities between populations, and achieve and uphold social equity.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Socioecological framework to increase diversity in clinical research.

References

  1. U.S. Food & Drug Administration. 2015–2019 drug trials snapshots summary report. FDA https://www.fda.gov/media/143592/download (2020).

  2. Mak, W. W. S. et al. Gender and ethnic diversity in NIMH-funded clinical trials: review of a decade of published research. Adm. Policy Ment. Health 34, 497–503 (2007).

    Article  Google Scholar 

  3. McCollum, A. D. et al. Outcomes and toxicity in African-American and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J. Natl Cancer Inst. 94, 1160–1167 (2002).

    Article  CAS  Google Scholar 

  4. Meta-Analysis Group In Cancer et al. Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. J. Clin. Oncol. 16, 3537–3541 (1998).

    Article  Google Scholar 

  5. U.S. Food & Drug Administration. Drug trials snapshots: ninlaro. FDA https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-ninlaro (2016).

  6. Landgren, O. et al. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood 107, 904–906 (2006).

    Article  CAS  Google Scholar 

  7. Holmes, L. Jr. et al. Black–white risk differentials in COVID-19 (SARS-COV2) transmission, mortality and case fatality in the United States: translational epidemiologic perspective and challenges. Int. J. Environ. Res. Public Health 17, 4322 (2020).

    Article  CAS  Google Scholar 

  8. Bierer, B. E. et al. Achieving diversity, inclusion, and equity in clinical research guidance document version 1.2. The MRCT Center of Brigham and Women’s Hospital and Harvard https://mrctcenter.org/diversity-in-clinical-research/download/2326/ (2021).

  9. Hsu, W. C. et al. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care 38, 150–158 (2015).

    Article  Google Scholar 

  10. George, S., Duran, N. & Norris, K. A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. Am. J. Public Health 104, e16–e31 (2014).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA

    Ashwarya Sharma & Latha Palaniappan

Authors
  1. Ashwarya Sharma
    View author publications

    Search author on:PubMed Google Scholar

  2. Latha Palaniappan
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Latha Palaniappan.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Related links

World Population Review: https://worldpopulationreview.com/continents

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sharma, A., Palaniappan, L. Improving diversity in medical research. Nat Rev Dis Primers 7, 74 (2021). https://doi.org/10.1038/s41572-021-00316-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41572-021-00316-8

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing